
|Videos|December 14, 2015
NOAC Dosing for Obese Patients vs. Non-Obese Patients
Katie Greenlee, PharmD, BCPS-AQ Cardiology, of the Cleveland Clinic discusses how NOAC dosing for obese patients differs from NOAC dosing for non-obese patients.
Advertisement
Katie Greenlee, PharmD, BCPS-AQ Cardiology, of the Cleveland Clinic discusses how NOAC dosing for obese patients differs from NOAC dosing for non-obese patients.
This video was recorded at the 2015 American Society of Health-System Pharmacists Midyear Meeting.
Newsletter
Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Pharmacy Times
1
FDA, ASH Experts Review Newly Approved Therapies in Hemophilia
2
New Data Highlights Pharmacists’ Expanding Roles in Hematologic Malignancies
3
Pharmacist Strategies for Managing Comorbid Depression and Diabetes
4
Pharmacy Deserts: A Crisis Health Care Providers Can Help Solve with Technology and Teamwork
5
















































































































































































































